Nymox Pharmaceutical NYMXF
OTC NYMXF
$0.04 -0.02 (-33.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Nymox Pharmaceutical (NYMXF) Long-Term Deferred Tax (2015 - 2019)

Updated

Nymox Pharmaceutical (NYMXF) reported Long-Term Deferred Tax of $1.4 million for Q4 2019, down 10.6% from $1.57 million a year earlier.

Analysis

Nymox Pharmaceutical (NYMXF) Long-Term Deferred Tax (2015 - 2019) Analysis & Trends

Dating back to Q4 2015, Nymox Pharmaceutical's Long-Term Deferred Tax record includes 5 quarters.

  • Long-Term Deferred Tax has a four-year compound annual growth rate of -23.5% (FY2015 to FY2019).
  • By year, Long-Term Deferred Tax came in at $1.57 million in FY2018 (-62.6%), $4.19 million in FY2017 (+1.0%), $4.15 million in FY2016 (+1.1%) and $4.1 million in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Nymox Pharmaceutical 6.12 Mn 5.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 1.40 Mn
Dec 31, 2018 1.57 Mn
Dec 31, 2017 4.19 Mn
Dec 31, 2016 4.15 Mn
Dec 31, 2015 4.10 Mn
API Access

Nymox Pharmaceutical Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=NYMXF&period=max&api_key=YOUR_API_KEY